abstract |
(57) Summary The present invention relates to the simultaneous, sequential or separate treatment of soft steroids, especially loteprednol, with at least one β 2 -adrenergic receptor agonist for treating allergic and / or respiratory tract diseases. A novel combination; a medicament comprising said combination; a method for producing such a medicament and a novel combination for producing a medicament for the simultaneous, sequential or separate treatment of allergic and / or airway diseases. |